跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,264 条关于
“mTOR inhibitors”
全部
17,264
临床试验
9,675
药物
3,275
机构
15
资讯
4,299
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
7个月前
Milken Institute and Ann Theodore Foundation Launch $575,000 Grant for mTOR Inhibitor Trial in Cutaneous Sarcoidosis
10个月前
Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy
3个月前
Montara Therapeutics Secures $1M Michael J. Fox Foundation Grant to Advance Brain-Selective mTOR Therapy for Parkinson's Disease
去年
Dual mTORC1/2 Inhibitor BI 860585 Shows Promise in Phase I Breast Cancer Trial
3年前
U.S. Tuberous Sclerosis Drug Market Projected to Reach $1.25 Billion by 2030, Growing at 23.1% CAGR
去年
Nab-Sirolimus Demonstrates Promising Outcomes in Advanced PEComa Treatment
去年
Ryvu Therapeutics Discovers Synergistic mTOR-AKT Inhibitor Combination for Colorectal Cancer Treatment
11个月前
Edinburgh Researchers Develop Anti-Cancer Drug Potentially 500 Times More Effective Than Current Treatments
4年前
Landmark TOSCA Registry Reveals New Insights into Tuberous Sclerosis Complex Management
第 1 页,共 430 页
上一页
下一页